Volume 14, Number 9—September 2008
Research
Pediatric Parapneumonic Empyema, Spain
Table 2
Serotype* | Barcelona, no. (%), n = 56 | Seville/Malaga, no. (%), n = 55 | Total no. (%), n = 111 | p value |
---|---|---|---|---|
1 | 27 (48) | 26 (47) | 53 (48) | 0.92 |
7F | 3 (5) | 11 (20) | 14 (13) | 0.02 |
3 | 5 (9) | 7 (13) | 12 (11) | 0.56 |
5 | 6 (11) | 3 (5) | 9 (8) | 0.28 |
14 | 4 (7) | 5 (9) | 9 (8) | 0.74 |
19A | 6 (11) | 2 (4) | 8 (7) | 0.27 |
9V | 2 (4) | 0 | 2 (2) | 0.50 |
6A | 2 (4) | 0 | 2 (2) | 0.50 |
8 | 0 | 1 (2) | 1 (0.9) | 1 |
19F | 1 (2) | 0 | 1 (0.9) | 1 |
*7-valent pneumococcal conjugate vaccine serotypes include 4, 6B, 9V, 14, 18C, 19F, 23F. Pleural fluid samples were collected in Barcelona from October 1, 2003, through June 30, 2006, and in Seville and Malaga from January 1, 2005, through June 20, 2006. Serotypes were determined by Quellung reaction or PCR testing or predicted based on complete multilocus sequence typing, as described in the text. Boldface represents a statistically significant result.
Page created: July 13, 2010
Page updated: July 13, 2010
Page reviewed: July 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.